NCT07496567 A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) Status RECRUITING Phase PHASE2/PHASE3
NCT07482176 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) Status RECRUITING Phase PHASE3
NCT07440225 A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) Status RECRUITING Phase PHASE2/PHASE3
NCT07390253 Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07317934 Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR) Status RECRUITING Phase PHASE3
NCT06856577 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06850922 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06839339 Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD Status NOT_YET_RECRUITING Phase PHASE2
NCT06556368 A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06495918 Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06223958 Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06011798 Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE) Status COMPLETED Phase PHASE2
NCT05990829 Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial Status UNKNOWN Phase PHASE4
NCT05891548 Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration Status COMPLETED Phase PHASE2
NCT05885503 Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular Edema Status RECRUITING Phase PHASE3
NCT05710471 Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E Status COMPLETED Phase PHASE4
NCT05704725 A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD) Status COMPLETED Phase PHASE3
NCT05683912 Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece Status COMPLETED Phase N/A
NCT05403749 A Study of Longer Interval of IVT IBI302 in Subjects With nAMD Status COMPLETED Phase PHASE2